Header Logo

Connection

DAVID LONARD to Lymphoma, Mantle-Cell

Back to Details
This is a "connection" page, showing publications DAVID LONARD has written about Lymphoma, Mantle-Cell.
DAVID LONARD
Connection Strength
0.222
Lymphoma, Mantle-Cell
  1. Inhibition of SRC-3 as a potential therapeutic strategy for aggressive mantle cell lymphoma. PLoS One. 2024; 19(4):e0289902.
    View in: PubMed
    Score: 0.222
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.